Treatment of Choroidal Metastasis from Epidermal Growth Factor Mutant Non-Small Cell Lung Cancer with First-line Osimertinib Therapy

PURPOSE: To illustrate the regression of a metastatic lesion through ophthalmic imaging and correlating findings with standard chest imaging and treatment with osimertinib, an oral chemotherapy agent specific to Epidermal Growth Factor Receptor + Non-small Cell Lung Cancer (EGFR+ NSCLC). CASE REPORT...

Descripción completa

Detalles Bibliográficos
Autores principales: N. Vu, Anderson, Mehta, Urmi V., Israelsen, Paul, Ignatius Ou, Sai-Hong, Browne, Andrew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PUBLISHED BY KNOWLEDGE E 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850857/
https://www.ncbi.nlm.nih.gov/pubmed/35194503
http://dx.doi.org/10.18502/jovr.v17i1.10178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850857/
https://www.ncbi.nlm.nih.gov/pubmed/35194503
http://dx.doi.org/10.18502/jovr.v17i1.10178

Ejemplares similares